Neurologic Manifestations of Hematological Disease

Author(s):  
Bayat Elham

A wide sprectum of hematologic disorders affect the central and peripheral nervous system. These disorders include porphyria, thrombotic thrombocytopenic purpura-hemolytic uremic syndromes, sickle cell disease, plasma cell dyscrasias, monoclonal gammopathy, primary systemic amyloidosis, primary systemic amyloidosis, Waldonstrom’s macroglobulinemia, myeloproliferative syndromes, cryoglobulinemia, and polycythemia vera. Some, like porphyria, cause both central and peripheral nervous system manifestations including sensory/motor peripheral neuropathy, dysautonomia, pain, seizures, and abdominal pain. Others such as sickle cell disease primarily affect the brain and cause both clinically apparent strokes associated with a vasculopathy of large intracranial blood vessels, as well as less obvious microstrokes that cause progressive cognitive decline if not treated.

2009 ◽  
Vol 16 (7) ◽  
pp. 814-818 ◽  
Author(s):  
E. E. Okuyucu ◽  
A. Turhanoglu ◽  
T. Duman ◽  
H. Kaya ◽  
I. M. Melek ◽  
...  

2002 ◽  
Vol 53 (1) ◽  
pp. 143-143
Author(s):  
Fereydoon Roohi ◽  
Roger W. Kula ◽  
Ramesh M. Gowda

1998 ◽  
Vol 8 (3) ◽  
pp. 535-543 ◽  
Author(s):  
R. Grant Steen ◽  
Wilburn E. Reddick ◽  
Raymond K. Mulhern ◽  
James W. Langston ◽  
Robert J. Ogg ◽  
...  

2010 ◽  
Vol 16 (2) ◽  
pp. 263-272 ◽  
Author(s):  
Mark C. Walters ◽  
Karen Hardy ◽  
Sandie Edwards ◽  
Thomas Adamkiewicz ◽  
James Barkovich ◽  
...  

2019 ◽  
Vol 3 (23) ◽  
pp. 3982-4001 ◽  
Author(s):  
Ann T. Farrell ◽  
Julie Panepinto ◽  
C. Patrick Carroll ◽  
Deepika S. Darbari ◽  
Ankit A. Desai ◽  
...  

Abstract To address the global burden of sickle cell disease (SCD) and the need for novel therapies, the American Society of Hematology partnered with the US Food and Drug Administration to engage the work of 7 panels of clinicians, investigators, and patients to develop consensus recommendations for clinical trial end points. The panels conducted their work through literature reviews, assessment of available evidence, and expert judgment focusing on end points related to: patient-reported outcomes (PROs), pain (non-PROs), the brain, end-organ considerations, biomarkers, measurement of cure, and low-resource settings. This article presents the findings and recommendations of the PROs, pain, and brain panels, as well as relevant findings and recommendations from the biomarkers panel. The panels identify end points, where there were supporting data, to use in clinical trials of SCD. In addition, the panels discuss where further research is needed to support the development and validation of additional clinical trial end points.


2018 ◽  
Vol 68 (2-3) ◽  
pp. 251-262 ◽  
Author(s):  
Thomas D. Coates ◽  
Patjanaporn Chalacheva ◽  
Lonnie Zeltzer ◽  
Michael C.K. Khoo

Author(s):  
Syed Asif Hasan ◽  
Mahmood Ahmad Boeisa ◽  
Yazid Taha Alandunesi ◽  
Abdulkarim Thumayl Alshammari ◽  
Diyaa Hisham Calcattawi ◽  
...  

Different organs can be affected secondary to sickle cell disease, including the central nervous system, kidneys, gastrointestinal tract, respiratory system, cardiovascular system, bone, and joints. This can lead to increased morbidity and mortality events among the affected patients. Osteoarticular complications represent a severe set of events for patients with sickle cell disease. These complications might include gouty, septic, juvenile, and erosive arthritis, dactylitis, bone infarction, and osteomyelitis. These are the most common complications reported in the literature, and some case reports even reported other types of complications that develop secondary to the previously mentioned ones. Adequate diagnosis might be challenging in some cases. Therefore, clinicians must be crucial in determining the appropriate clinical and radiographic manifestations. Treating these cases is also challenging. Consequently, clinicians should be aware of these complications to enhance the prognosis of the affected patients. Further research is needed for the standardization of the diagnostic and management approaches in these events.


2020 ◽  
Vol 11 ◽  
Author(s):  
Plamen Bokov ◽  
Houmam El Jurdi ◽  
Isabelle Denjoy ◽  
Claudine Peiffer ◽  
Noria Medjahdi ◽  
...  

2020 ◽  
Author(s):  
Tiago Lopes ◽  
Samir K Ballas ◽  
Jamille Evelyn Rodrigues Souza Santana ◽  
Pedro de Melo-Carneiro ◽  
Lilian Becerra de Oliveira ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document